Virtus Holding, building business since 1977, is engaged in trade & service of a wide range of products in our core fields of Health, Science & Education. We have embraced Information Technology as an enabler for standardizing workflows and providing decision support tools.
Over 750 people, employed across a number of operating companies, under the aegis of the Al Essa, Virtus & TMC groups, in Kuwait, UAE, Qatar & India deliver a superior customer experience (Turnover 2019 – USD 120 Million).
People are our most important resource: nurturing and enabling them, developing critical thinkers and empowering stewards capable of driving growth. Proactively managing our HR requirements, we are increasing headcount annually, constantly seeking both fresh and experienced hands in various spheres of our activity.
Growth requires discipline: the discipline to engage in continuous improvement, to continually invest in training, to meet commitments of performance and quality, to drive future growth through proof of concept pilots, to collect receivables, to be fiscally prudent, to deliver consistently growing dividends: and at all times be drivers of change that challenge status quo in delivering a "Superior Customer Experience".
Building on the foundation of "A Commitment to Excellence" in the products and services offered, "Enabling Excellence" in our people and processes, we are now "Powering Excellence"
Established in 2007 with offices in Abu Dhabi, Dubai and Al Ain, Virtus Trading LLC (VTL), from its humble beginnings, today employ more than 35 professionals who have contributed to the 33 Million AED revenue in 2019.
VTL offers customers advanced medical solutions for Acute Care, Medication Management, Health Informatics, Respiratory Therapy and Diagnostics adhering to strict international standards, and the highest principles of business ethics and voluntary self-regulation, that have earned it a proven record of market place honesty and integrity. We strive to be a trend setter in both technology and design and continues to offer innovative solutions in the medical field with plans to expand into the regional market with its current portfolio of products as well as any new products considered lucrative.